|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| C07K 16/28 | (2006.01) | ||
| C07K 16/30 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2961771 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14708507.0 |
| Date of filing the European patent application | 2014-02-24 | |
| (97) | Date of publication of the European application | 2016-01-06 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-01 |
| (46) | Date of publication of the claims translation | 2020-03-10 |
| (86) | Number | PCT/EP2014/053490 |
| Date | 2014-02-24 |
| (87) | Number | WO 2014/131712 |
| Date | 2014-09-04 |
| (30) | Number | Date | Country code |
| 13156686 | 2013-02-26 | EP |
| (72) |
BACAC, Marina, CH
HOFER, Thomas, CH
HOSSE, Ralf, CH
NEUMANN, Christiane, CH
KLEIN, Christian, CH
MOESSNER, Ekkehard, CH
UMANA, Pablo, CH
WEINZIERL, Tina, CH
|
| (73) |
Roche Glycart AG,
Wagistrasse 10, 8952 Schlieren,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Bispecifinės T ląstelę aktyvinančios antigeną surišančios molekulės, specifinės CD3 ir CEA antigenams |
| BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES SPECIFIC TO CD3 AND CEA |
| Payment date | Validity (years) | Amount | |
| 2024-01-23 | 11 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2025-02-24 |